TRLVNYSEMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Trulieve Cannabis Corp.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026
$10.28+0.27 (+2.70%)
Close on Oct 19, 2026
- Market cap
- $1.98B
- P/E (TTM)
- –
- Dividend yield
- –
Trulieve Cannabis statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| Market Cap | $1.98B | $164.85M |
| Enterprise Value | $1.74B | $87.06M |
| PS Ratio | 1.74 | 3.60 |
| P/FCF Ratio | 9.77 | 17.44 |
| P/OCF Ratio | 8.10 | 13.32 |
Enterprise value
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| EV / Sales | 1.53 | 2.43 |
| EV / FCF | 8.60 | 20.97 |
Income (trailing twelve months)
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| Revenue | $1.14B | $57.94M |
| Gross Profit | $677.39M | $90.47M |
| Operating Income | -$277.26M | -$21.44M |
| Pretax Income | -$325.93M | -$14.45M |
| EBITDA | -$162.92M | -$16.91M |
| EPS (Diluted) | -$2.46 | -$0.83 |
Margins
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| Gross Margin | 59.5% | 52.3% |
| Operating Margin | -24.3% | -44.5% |
| Pretax Margin | -28.6% | -13.0% |
| EBITDA Margin | -14.3% | -31.3% |
| FCF Margin | 17.8% | -8.85% |
Returns
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | -14.0% | -37.8% |
Growth
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -3.90% | 6.01% |
| FCF Growth (YoY) | 151.3% | 2.34% |
| Revenue Growth (3Y CAGR) | -1.02% | 2.25% |
| Revenue Growth (5Y CAGR) | 17.8% | 6.42% |
Balance sheet
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $325.42M | $62.42M |
| Total Debt | $89.39M | $120.13M |
| Net Cash (Debt) | $236.03M | $15.68M |
| Net Cash Per Share | $1.23 | $0.66 |
| Working Capital | $469.77M | $75.77M |
Financial position
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| Current Ratio | 5.94 | 3.30 |
| Quick Ratio | 3.46 | 2.39 |
| Debt / FCF | 0.44 | 5.05 |
| Interest Coverage | -4.88 | -7.12 |
Cash flow (trailing twelve months)
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| Operating Cash Flow | $244.44M | -$12.35M |
| Capital Expenditures | -$41.88M | -$1.06M |
| Free Cash Flow | $202.56M | -$20.28M |
| FCF Per Share | $1.05 | -$0.42 |
Efficiency
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| Asset Turnover | 0.46 | 0.38 |
| Inventory Turnover | 2.16 | 2.67 |
| Revenue Per Employee | $227.81K | $398.96K |
| Employee Count | 5,000 | 74 |
Dividends and yields
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| FCF Yield | 10.2% | -9.07% |
Shares
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| Shares Outstanding | 192,565,000 | 58,179,650 |
| Shares Change (YoY) | 1.44% | 11.1% |
| Shares Change (QoQ) | 0.04% | 0.54% |
| Float | 182,391,000 | 49,173,100 |
| Shares Held by Insiders | 5.28% | 11.6% |
Taxes
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| Income Tax | $144.75M | $91.50K |
Scores
| Measure | Trulieve Cannabis | Industry median |
|---|---|---|
| Altman Z-Score | 0.40 | -0.24 |
| Beneish M-Score | -2.88 | -2.62 |
Calculated by StockData from Trulieve Cannabis's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.